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Anomalous psychedelic experiences:  




This paper explores the nature of psychedelically-induced anomalous experiences for what 
they reveal regarding the nature of ‘expanded consciousness’ and its implications for 
humanistic and transpersonal psychology, parapsychology and the psychology and underlying 
neuroscience of such experiences. Taking a multidisciplinary approach this essay reviews the 
nature of ten transpersonal or parapsychological experiences that commonly occur 
spontaneously and in relation to the use of psychedelic substances, namely synaesthesia, 
extra-dimensional percepts, out-of-body experiences, near-death experiences, entity 
encounters, alien abduction, sleep paralysis, interspecies communication, possession, and psi 
(telepathy, precognition, and clairvoyance and psychokinesis).  
 



































Anomalous psychedelic experiences:  




Quite some prominent literature and research exists with regards to the induction of genuine 
spiritual, mystical and peak experiences with psychedelic substances (e.g., Griffiths, Richards, 
McCann & Jesse, 2006; Huxley, 1954), but exploration of the associated ‘anomalous’ 
experiences that commonly accompany such pharmaco-mystical excursions is more obscure. 
Nevertheless, ever since the beginning of the 20th century when Western scientists and 
academics began earnestly turning their attention to psychedelics, there has been a clear 
association between the use of these substances and both the mystical and ostensibly 
paranormal experience. Indeed, those people most readily associated with the discovery and 
popularization of psychedelics also witnessed and explored both the transpersonal and the 
parapsychological dimensions that these substances induced, such as Albert Hofmann, 
Humphrey Osmond, John Smythies, Aldous Huxley, Gordon Wasson, Timothy Leary, Ken 
Kesey, Duncan Blewett, Walter Pahnke, James Fadiman and Stanislav Grof, to name but a 
few (Luke, 2006a, 2012).  
 
Leaving aside what are termed solely mystical or spiritual experiences, this essay investigates 
the relationship between psychedelic substances and so-called anomalous experiences. The 
term ‘anomalous’, somewhat broader and less freighted than the term ‘paranormal’, and 
somewhat more neutral than the term ‘transpersonal’, here refers to “…an uncommon 
experience (e.g., synaesthesia), or one that, although it may be experienced by a significant 
number of persons (e.g., psi experiences), is believed to deviate from ordinary experience or 
from usually accepted explanations of reality according to Western mainstream science” 
(Cardeña, Lynn & Krippner, 2014, p.4). More simply, “anomalous experiences... are distinct 
from our ordinary state of awareness or contravene assumptions about reality” (Holt, 
Simmonds-Moore, Luke & French, 2012, p.2).  
 
Given the broad range of possible anomalous experiences, numbering over a hundred in one 
systematic review and categorisation (White & Brown, 1997), the current paper will focus on 
only a few examples typically occurring with psychedelics, for which the author has 
conducted reviews published elsewhere (Krippner & Luke, 2009; Luke, 2010, 2011, 2012, 
2014; 2017, 2019; Luke & Kittenis, 2005; Luke & Terhune, 2013). These anomalous 
psychedelic experiences include synaesthesia, extra-dimensional percepts, out-of-body 
experiences, near-death experiences, entity encounters, alien abduction, sleep paralysis, 
interspecies communication, possession, and psi (telepathy, precognition, and clairvoyance 
and psychokinesis). Somewhat beyond the scope of this paper, there are of course many more 
chemically-mediated anomalous or potentially peak experiences that occur, and a broader 
range of 45 such experiences has been catalogued and classified into three major and six 
minor categories by Grof (2000): The three main categories being, i) experiential extension 
within space-time and consensus reality (e.g., planetary consciousness, embryonal, fetal and 
phylogenetic experiences); ii) experiential extension beyond space-time and consensus reality 
(e.g., mental mediumship, entity encounters and cosmic consciousness), and iii) transpersonal 
experiences of a psychoid nature (i.e., having apparent physical concomitants, e.g., physical 
mediumship, UFO phenomena and yogic siddhis). Anomalous experiences in this paper all 
belong to Grof’s second category, with the exception of synaesthesia, which, if anywhere, 
falls into the first category.  
 
Given the interdisciplinary nature of the research relating to these experiences, the paper 
borrows widely, but by no means exhaustively, from parapsychology as well as transpersonal 
and religious studies, anthropology, ethnobotany, psychopharmacology, neurobiology, 
psychiatry, psychotherapy, and even critical theory. Empirical evidence shedding light on 
these experiences will be discussed, where available, for some insights on the possible 
ontology of these experiences. Regarding ontology, for the purposes of this paper experiences 
are regarded to be at least subjectively genuine, though they are not necessarily objectively 




Synaesthesia is an unusual but non-pathological condition in which a stimulus will 
consistently and involuntarily produce a second concurrent experience. An example includes 
grapheme-colour synaesthesia, which is a common form of the congenital condition where 
letters and numerals will involuntarily elicit experiences of colour. Synaesthesia qualifies as 
an anomalous experience due primarily to its uncommonness, being estimated to occur in 
some form in up to 4% of the general population (Simner et al., 2006), and despite some 
researchers once doubting it as a genuine perceptual experience it is now considered to be 
real, i.e., some people really do see sounds or taste colours (Marks, 2014). As such it is only 
an anomaly in prevalence but not anymore an anomaly in its deviance within Western 
mainstream science. Furthermore, save for the possible association between synaesthesia and 
aura vision (Milán et al., 2012) – an experience reported to occur under the influence of 
psychoactive drugs by 46% of users (Luke & Kittenis, 2005) – a professed spiritual 
dimension to the mundane, albeit odd, experience of synaesthesia is not especially 
pronounced among experiencers.  
 
Most likely psychedelic synaesthesia would fall within Grof’s (2000) transpersonal category 
of ‘experiential extension within space-time and consensus reality’, if at all. Nevertheless, 
synaesthesia-like experiences occur quite widely across psychedelic users and across different 
substances (for a review see, Luke & Terhune, 2013). One good example comes from Owsley 
Stanley, the first sound engineer of the proto psychedelic rock band Grateful Dead. Stanley 
was also one of the 1960s’ pioneering underground LSD chemists and would combine his 
interests, and consequently his senses, leading him to see the waves of sound coming out of 
the speakers, and so he arranged the sound system spatially to maximize this effect 
(McKenna, 1992).  
 
Figures for the frequency of occurrence within individuals are scant, but prevalence rates 
indicate that psychedelic synaesthesia occurs in anywhere from 10% (mescaline; Hartman & 
Hollister, 1963) up to 100% of participants (mescaline; Simpson & McKellar, 1955) in small 
group experiments intended to induce synaesthesia. Experiments merely noting subjective 
reports of synaesthesia under the influence of psychedelics in the laboratory produce 
prevalence rates of between 10% (MDMA; Studerus, 2013) and 57% (Salvia divinorum; 
Addy, 2010), and demonstrate that this prevalence is dose dependent with psilocybin, 
occurring in up to 50% of participants receiving the highest dose versus 0% with the lowest 
dose and placebo (Studerus, 2013). Surveys report similar maximum figures with up to 50% 
(various psychedelics; DeGracia, 1997) to 57% (LSD; Luke, Terhune & Friday, 2012) of 
‘recreational’ psychedelic users reporting substance-induced synaesthesia across the lifetime, 
with classic serotonergic tryptamines (e.g., LSD, psilocybin) being the most likely to induce 
experiences, followed by phenythlamines (e.g. mescaline), then NMDA-antagonists (e.g., 
ketamine) and then other drugs (Luke, Terhune & Friday, 2012).  
 
One theory proposes that at least some types of congenital synaesthesia may be mediated by 
serotonergic action (Brang & Ramachandran, 2008), hence the predilection for the experience 
with tryptamine psychedelics. Typical explanations for this neurochemical action offer that 
the experience of synaesthesia is ordinarily suppressed but disinihibition can give rise to the 
experience, such that congenital synaesthetes are normally hyper activated cortically (e.g., 
Grossenbacher, 1997). However competing theories and some, albeit inconclusive, evidence 
suggests that at least some types of congenital synaesthesia, such as grapheme-colour, are 
anatomically mediated, and due to excess cross-activation in adjacent brain regions, termed 
hyperconnectivity (e.g., Hubbard, Brang & Ramachandran, 2011).  
 
There may well be multiple aetiologies for congenital synaeathesia, as there are many types, 
however determining the nature of the relationship between induced and congenital 
synaesthesia is crucial, though there is no common agreement about whether psychedelic 
experiences are genuinely synaesthetic or just synaesthesia-like (for a review see Terhune, 
Luke & Cohen Kadosh, 2017). The four defining features of congenital synaesthesia are its 
consistency over time within individuals (e.g., Tuesday is always green), automaticity (occurs 
without effort), specificity (e.g., B minor is chartreuse), and access to consciousness. Of these 
four criteria only the access to consciousness is incontrovertible with psychedelic 
synaesthesia, specificity is sometimes absent (e.g., the concurrent visual experience to sound 
may be complex), and automaticity and consistency have not been sufficiently tested for 
under controlled conditions, save for a recent study exploring LSD-induced synaesthesia 
under laboratory controlled conditions (Terhune et al., 2016). This was the first such 
experiment conducted in 50 years and, unlike previous direct experimental studies (e.g., 
Hartman & Hollister, 1963; Simpson & McKellar, 1955) this study explored drug-induced 
synaesthesia for both consistency and inducer specificity using behavioural measures in a 
controlled manner. Furthermore, this was the first direct psychedelic synaesthesia experiment 
to employ a blind placebo-controlled design. 
 
Unfortunately that study did not produce evidence to support the existence of consistency or 
inducer specificity of LSD-induced grapheme-colour and sound-colour synaesthesia. This 
does not rule out that such consistency and specificity is not possible with psychedelic-
induced synaesthesia, as occurs with congenital synaesthesia, but that the current 
methodological approach did not support this, perhaps due to the simplicity of the stimuli 
used, which may be dissimilar to those occurring naturally. However, participants did report 
more spontaneous synaesthesia-like experiences (concurrent visual movements, experiences 
of touch and entoptic patterns) occurring with the visual and, especially, the auditory stimuli 
under LSD than compared to the control condition. Although it should be noted that colour 
concurrents were not explicitly observed, perhaps indicating why the experiment was not 
successful in producing LSD-induced consistency and inducer specificity of grapheme-colour 
and sound-colour synaesthesia.  
 
In any case, it is probable that with congenital synaesthesia both consistency and specificity 
arise from the consolidation of inducer-concurrent pairings over time (perhaps years) and so 
are not evident in short-lived substance-induced instances. If this is the case then psychedelic-
induced synaesthesia would be unlikely to ever produce consistency and specificity effects in 
tests, unless the experience was especially prolonged. It is hard to speculate how long 
someone would need to be tripping for to achieve such an effect, given that evidence suggests 
that congenital synaesthesia seemingly begins development as an infant (Simner & Bain, 
2013).  
 
One possibly is to test those rare people reporting hallucinogen persisting perceptual disorder 
manifesting as synaesthesia-like symptoms. One such individual presenting such a condition 
following the ingestion of a large dose of the phenethylamine psychedelic 2C-B some seven 
years prior was successfully tested for face-colour synaesthesia automaticity and consistency 
using a Stroop-like face colour priming task (Yanakieva, Luke, Jansari & Terhune, 2019). 
The positive findings of this case study led us to speculate that the hallmark features of 
congenital synaesthesia are a product of developmental overlearning and that psychedelic-
induced synaesthesia-like experiences do not ordinarily exhibit these features as they are so 
transitory, although in some cases, such as accidental overdose leading to persistent 
perceptual changes, these features may eventually manifest. Such a discovery has 
implications for understanding the underlying neural mechanisms of congenital synaesthesia 
and the experience of perceiving auras.  
 
2. Extra-dimensional percepts 
 
Typical synaesthetic experiences with psychedelics are of the audio-visual (inducer-
concurrent) type, such that sound, particularly music, elicits colourful images, often 
geometric, although the geometric imagery also occurs in the absence of synaesthesia too. 
Such geometric forms appear to be relatively common, with 64% of first-time ayahuasca 
users reporting them (Barbosa, Giglio & Dalgalarrondo, 2005). Experimenting extensively 
with mescaline and perception nearly a century ago Klüver (1926) named these geometric 
percepts form constants, due to the consistency of their forms, which he categorized as 
lattices, cobwebs, tunnels, and spirals. Later researchers used cocaine, LSD and cannabis, as 
well as a variety of non-drug means of inducing geometric visual percepts, including 
transcranial magnetic stimulation (see Billcock & Tsou, 2012; Dronfield, 1996) and they 
defined similar categorizations. Using form constants as a means of explaining Paleolithic 
rock art, Lewis-Williams and Dowson (1988) combined these various categories to make six 
forms: grids, lattices, dots, zigzag lines, nested curves and filigrees. They called these forms 
entoptic phenomena (derived from entoptical phenomena by Helmholtz, 1925), defined as 
“visual sensations derived from within the optic system anywhere from the eyeball to the 
cortex” (Lewis-Williams and Dowson (1988, p.202). More recently Dronfield (1996) opted 
for seven distinct forms.  
 
Renderings of these geometric percepts on paper obviously look two-dimensional, but using 
mathematical operations the various patterns can be inferred from the various cortical 
mechanisms used to process edges, contours, surfaces and textures (Ermentrout & Cowan, 
1979). This model is “based on the assumption that the form of the retino-cortical map and 
the architecture of [the visual cortex region] V1 determine their geometry” (Bresloff et al, 
2002, p.474). Nevertheless, it has been noted that, “the experience of mental imagery is 
qualitatively different from the experience of seeing a 2D picture” (Froese, Woodward & 
Ikegami, 2013, p.205). Furthermore, these psychedelic geometrical percepts have the 
tendency to appear to belong to the external objects in view and follow their contours rather 
than just free-floating idly as hallucinatory optic system percepts might be expected to (Luke, 
2010). Experimenting with mescaline Klüver (1926, p505) observed that “the designs [as on 
rugs] seem to be localized on walls, on the floor, etc.” as did Smythies (1956, p.81) who noted 
that the “hallucinations are spatial and coloured entities and may possess not only a high 
degree of internal organization, but may also be closely integrated into the ‘veridical’ 
remainder of the visual field in which they occur.” 
 
Having geometric percepts apparently projected seamlessly onto the outer world is the least 
ontological concern however, as users of psychedelics, especially tryptamine-based 
substances such as DMT and ayahuasca, occasionally report percepts with more than the 
usual three spatial dimensions (see Luke, 2010). For example, ayahuasca researcher Shanon 
(2002, p.88), reports that, “at times, the geometric patterns may seem to defy ordinary real-
world Euclidean geometry; some persons that I interviewed made reference to higher orders 
of spatial dimensionality.”  Indeed such extradimensional phenomenological reports with 
ayahuasca are littered across the academic literature (see Luke, 2010). Attempting to survey 
the number of reports, a review in November 2008 of all 142 ayahuasca trip reports in the 
Vaults of Erowid (www.erowid.org) revealed 30 reports containing the search term 
“dimension”, and 5 of these discussed extra-dimensional percepts, which is 3.5% of all 
ayahuasca reports (Luke, 2010). Reports are screened before posting for accuracy, 
believability, interest and quality and only about 20% get published so generalizability is 
questionable, but they are of high quality and indicate that such percepts are seemingly 
somewhat widespread, though certainly not common. The following accounts give a flavor of 
the experiences:  
 
After a point i [sic] came to realize that the entire prismatic hyperdimensional wall of 
images that assailed me was itself one conscious entity (Scotto, 2000) 
 
Flying through a multidimensional place of pure vision and thought, I saw endless 
arches of golden salamanders, flowing through the very fabric of space & time, their 
colors changing and rotating like countless kaleidoscopes (Satori, 2003). 
 
Similar reports are also extant for experiences with DMT (the main active chemical in 
ayahuasca) with nearly all high dose participants in Strassman’s (2001) structured laboratory 
study reporting visual-spatial percepts as being either multi-dimensional or beyond 
dimensionality (Strassman, personal communication, 2008, 6th October). DMT experience 
cartographer Meyer (1994) was well aware of the these percepts too and indicated that the 
third and deepest of his supposed levels of experience involves three or higher-dimensional 
space, a classification which is justified by 15% of DMT trip reports on Erowid specifically 
reporting extra-dimensional percepts (Luke, 2010).  
 
The experience of such 3D-defying geometries, albeit uncommon, seems to be in little doubt. 
The problem remains of how, informed by a flat sphere retina, essentially a 2D plane, 
misfiring neurons that code for edges, contours, surfaces and textures can give rise to percepts 
with more than three spatial dimensions, given that it is not possible to imagine greater than 
three-dimensional space let alone perceive it in ordinary states of consciousness. The solution 
to this problem is also embedded in an even greater mystery relating to the mind-body 
problem, that of understanding how light, coded as electrochemical signals in the brain, gives 
rise to a functionally veridical 3D percept of the world. Despite Ermentrout & Cowan’s  
(1979) elegant computational model of form constants, no amount of mathematics can 
sidestep this conundrum either, for the ‘hard problem’ of consciousness cannot be solved 
algebraically. As Cowan (2013) admitted after a lengthy lecture to neuroscientists explaining 
the mathematics of his model of 2D geometrical percepts, “you’re basically seeing your own 
visual architecture,” leading to the absurd regress that something within the visual system sees 
itself. This seemingly impossible perceptual feat, which presumes meta-optic systems within 
the optic system itself, is what Froese et al. (2013) somewhat understatedly call the “strange 
subjective experience of looking into oneself, where the patterns we see directly expose the 
underlying operation of our brains” (p.207, italics added). 
 
However, given the nature of apparently veridical vision in congenitally blind individuals 
having near-death experiences, termed mindsight (Ring & Cooper, 2008), and the report of 
the direct perception with psychedelics of events that are not within view, such as molecules 
or absent relatives (Luke, 2012), could vision in extreme altered states of consciousness be 
informed by a kind of clairvoyance? This issue will be evaluated in the penultimate section of 
this paper, but meanwhile the perception of apparently 3+D spatial arrangements begs some 
questions about the nature of exceptional psychedelic vision and even ordinary perception 
(Luke, 2010).  
 
3. Out-of-body experiences 
 
An out-of-body experience (OBE) is the perception that one’s self or centre of awareness is 
located outside of the physical body. Out-of-body experiences are no strangers to psychedelic 
users, indeed the discover of LSD, Albert Hofmann (1983), had an OBE on his first ever LSD 
trip in 1943 (he also experienced synaesthesia on that occasion). A review of the various 
surveys into substance use and OBE (Luke, 2012) indicates that, of those claiming to have 
had at least one OBE, between 13% (Palmer, 1979) and 37% (Blackmore, 1982) occurred 
when taking drugs, most often LSD or marijuana. On average 44% of psychoactive drug users 
(excluding alcohol, nicotine, caffeine & prescription drugs) reported OBEs under the 
influence (Luke & Kittenis, 2005), rising to between 40% (DeGracia, 1995) and 53% 
(Kjellgren & Norlander, 2000-2001) of those using psychedelics in general, 54% of those 
using cannabis (Tart, 1971), and 62% of those using ayahuasca (Luke, 2009b).  
 
Drug users were also significantly more likely to have had an OBE than non-drug users, with 
frequency of psychedelic use also associated with reported OBEs (Luke, 2017). Seemingly, 
the most common inducers of OBEs are cannabis, psychedelics (especially DMT), and 
dissociatives such as ketamine and nitrous oxide (Luke, 2012; Luke & Kittenis, 2005). One 
contributory factor for the high incidence of OBEs with DMT and ketamine is that OBEs 
occur more often when the person is quiescent and lying down (Cardeña, 2005), as is typical 
of DMT and high dose ketamine trips, because of their debilitating effects.  
 
Nevertheless, ketamine, which is of particular interest and has been shown to induce OBEs 
and autoscopy far more often than other (non-anaesthetic) psychedelics (Wilkins, Girard, & 
Cheyne, 2011), produces other phenomenological features which indicate that it is the 
substance itself rather than being supine that is the primary inducer of the K-OBE. To 
elucidate, it seems apparent that the degree of general anaesthesia induced by ketamine is 
relative to one’s motor control ability and what Grosso (1976) identified as the degree of 
being out-of-body (Luke, 2012): Factors which are more pronounced with the positive S-
isomer of ketamine rather than the negative isomer (Domino & Warner, 2010). Such 
relationships between sensory and motor impairment and reported body image have 
elsewhere been found with local anaesthesia (Paqueron et al., 2003), though not full blown 
OBEs. However, with ketamine there appears to be a relatively changing gradation in 
increased anaesthesia, body dysmorphia (e.g., micro- and macro-somatognosia) and motor 
control that proceeds as the dosage increases and the trip intensifies towards a full-blown out-
of-body experience, total anaesthesia, and ultimately no motor control, and which reverse in 
affect as the drug effects subside (Luke, 2012). Body image distortions are also more 
prevalent among OBE reporters generally (Cardeña & Alvarado, 2014). 
 
Little has been discussed theoretically about drug induced OBEs per se (though see the 
following section on near-death experiences), and no experimental research has yet been 
conducted, but they are generally considered to be similar experientially to non-drug OBEs 
(Blackmore, 1986), though a systematic phenomenological comparison is still needed to 
support this. Nevertheless, explanations regarding drug-induced OBEs can be considered in 
terms of those provided for OBEs more generally.  
 
The main competing theories are those of projection – that the person’s consciousness 
genuinely leaves the body and is able to observe the world from a disembodied perspective – 
versus psychological, psychophysiological and neurological models, that suppose, for 
example, that the OBE is either an imaginary or hallucinatory experience, a reconstruction 
from flying dreams, or a failure to integrate proprioceptive, tactile and visual information in 
the temporal-parietal junction (for an overview see Cardeña & Alvarado, 2014). There is 
currently no conclusive position: the imaginary and hallucinatory arguments are somewhat 
circular; despite many unproven reports the laboratory evidence for veridical OBE 
perceptions, and therefore projection, is somewhat slim and can in any case be accounted for 
by travelling clairvoyance (see the latter section on psi); and the neurological evidence does 
not rule out genuine disembodiment but does contribute some probable physiological 
mechanisms involved. The fact that certain psychoactive substances produce a proclivity for 
OBEs can provide neurochemical insights into this experience that ultimately have to be 
incorporated into any explanation. Nevertheless any complete theory will likely also require a 
deep consideration of the ontological and philosophical perspectives regarding the hard 
problem of consciousness and not just neurocognitive viewpoints. The same goes for near-
death experiences.  
 
4. Near-death experiences 
 
Out-of-body experiences are also a common core feature of near-death experiences (NDEs) 
and occur in 37% of NDEs (Ring, 1980). In Albert Hofmann’s (1983) seminal LSD trip, 
having an OBE lead him to think at the time that he must be dead. Other features occurring 
during the NDE include ineffability, peace, unusual noises, seeing a dark tunnel, meeting 
spiritual beings, sentient bright light, panoramic life review, supernatural rescue, sensing a 
border or limit, and coming back to the body (Greyson, 2014). Despite a lack of consensus 
NDEs have been defined as “unusual, often vivid and realistic, and sometimes profoundly 
life-changing experiences occurring to people who have been physiologically close to death, 
as in a cardiac arrest or other life-threatening conditions, or psychologically close to death as 
in accidents or illnesses in which they feared they would die” (Greyson, 2014, p.334). Two 
psychedelic-NDE theories are here discussed but see Greyson (2014) for an overview of 
alternative theories, which, as with OBEs, are divided between those that support 
disembodied consciousness and those that deny it, but all of which currently remain 
inconclusive.  
 
Few prevalence statistics are available for psychedelically induced NDEs. In one survey 32% 
of psychedelic users reported the experience of dying, rebirth, or memory of a past life under 
the influence of drugs (Luke & Kittenis, 2005) with such experiences being particularly 
associated with 5-MEO-DMT, being the second most common of 17 transpersonal events to 
occur with this substance, and observed to occur elsewhere too (Roney-Dougal, 2001; Shulgin 
& Shulgin, 1997). In the same survey such death-related experiences were also the most 
common experience, after OBEs, to be reported to occur with ketamine (Luke & Kittenis, 
2005). Prevalence figures for those experiencing NDEs under the influence of ketamine range 
from 12% (Jansen, 2001) to 40% (Corazza, 2010) of ketamine users, nevertheless it is unclear 
how often it occurs for these individuals as those in Corazza’s (2008) study had used 
ketamine between 10 and 2000 times (Luke, 2012). It is also noted that ketamine appears to 
have multiple effects in the brain and multiple experiential features, some of which include 
those of the NDE (Greyson, 2000; Parker, 2001) so at best, ketamine and 5-MEO-DMT, 
particularly, and other psychedelics more generally (e.g., DMT), can be thought of only as 
occasional NDE triggers.  
 
In a recent data mining study over 20,000 psychedelic ‘trip reports’, covering 165 different 
psychedelic substances publically available on the erowid.org website were compared to 625 
NDE subjective reports using a semantic analysis (Martial et al., 2019). The analysis 
identified ketamine as the substance with the highest semantic similarity to NDE reports, 
followed respectively by Salvia divinorum, peyote, LSD, 5-MEO-DMT, psilocybin and DMT 
(in 7th place) somewhat supporting the survey research (Luke & Kittenis, 2005).   
 
4.1. Ketamine and NDEs 
 
Given the noted similarity of aspects of the ketamine experience to that of the NDE (Morse, 
Venecia & Milstein, 1989; Rogo, 1984) a neurochemical model of NDE has been proposed 
based upon the action of ketamine (Jansen, 1990). Ketamine acts by binding to the 
phencyclidine (PCP) site of the N-methyl-D-aspartate (NMDA) receptor, blocking the action 
of the neurotransmitter glutamate. Jansen indicated that potentially life-threatening 
circumstances (e.g., hypoxia, ischemia, hypoglycemia, temporal lobe epilepsy) can initiate a 
glutamate flood, which results in neurotoxicity through the over-activation of the NMDA 
receptors. This NDE trigger may be accompanied by a flood of neuroprotective agents that 
also bind to the NMDA receptors preventing damage, in much the same way as ketamine. 
Like Grinspoon and Bakalar’s (1979) speculation that the brain synthesizes a chemical similar 
to ketamine in times of stress, Jansen proposed that endopsychosins, which bind to the same 
receptor site as ketamine, would be discovered as the neuroprotective agents that cause an 
altered state of consciousness (ASC), like that of ketamine, termed the NDE. 
 
Despite several candidate neurochemicals – alpha/beta-endopsychosin (Jansen, 1990), N-
acetyl-aspartyl-glutamate, kynurenic acid, magnesium (Jansen, 2004) and agmatine (Thomas, 
2004) – no compelling endogenous NDE-ogens have as yet been discovered (Greyson, 2000; 
Smythies, 2011). Further criticisms of Jansen’s model consider the disparity in emotional 
affect in NDEs and K-NDEs, with ketamine experiences thought to be more fearful, though 
this is somewhat unfounded as NDE’s can also be frightening experiences and ketamine is 
most often a pleasant or fearless experience (see Luke, 2012). It is also contested that non-
NMDA antagonists like LSD also induce occasional NDE features (Parker, 2001), although 
Jansen (1997) insists such features are typical with ketamine but not other drugs, though 
reviews by Luke (2012, 2017) and recent semantic analysis data mining research (Martial et 
al., 2019) suggests otherwise.  
 
To date the only systematic exploration of the ketamine hypothesis, besides Jansen (2001), is 
that of Corazza (2008), who compared 36 cases of apparent NDEs induced by ketamine with 
36 cases of NDEs reportedly caused by a cardiac arrest or other life threatening 
circumstances. Both groups showed a high degree of similarity in certain experiential 
features, with both groups having a roughly equal prevalence of experiences involving altered 
perceptions of time, speeded up visions, and the occurrence of ESP, but the ketamine group 
were more likely to report unity with the universe, and the cardiac groups were more likely to 
report dissociation from the body, visions of light, and encounters with deceased or religious 
beings. However, Corazza asserted that the evidence indicates that NDEs can be induced 
through ketamine, although they may not be identical to those occurring naturally. 
Nevertheless, the ketamine participants were recruited on the premise that they felt that they 
had had an NDE on ketamine and focused only on their NDE-like ketamine experiences not 
the dozens or possibly thousands of other ketamine trips they had that did not resemble NDEs, 
although such figures are not reported by Corazza (Luke, 2009a). Assuming ketamine NDEs 
to be genuine, ultimately, however, the question remains of whether chemically induced 
NDEs utilize alternative pathways or the actual NDE pathway (Fracasso & Friedman, 2011) 
and further research is needed.  
 
Returning to the discussion regarding ketamine and OBEs, another question may be asked as 
to why anaesthesia should accompany an OBE/NDE: Does the anaesthesia cause the 
perception of being out of one’s body, and therefore leads to a feeling of dying or of having 
died, or does the near-death experience provoke an OBE and subsequent anaesthesia as a 
defence against likely pain, or merely as an accidental yet useful concomitant of being 
disembodied? In any case the natural anaesthesia associated with NDE/OBEs is particularly 
beneficial in painful circumstances, as often occurs in an NDE. Observing the ketamine 
experience from the recipient’s perspective, it appears that the ketamine-induced anaesthesia 
occurs because one’s consciousness is no longer connected to one’s body, and certainly the 
OBE and anaesthesia are intimately connected, but why and how deserve further investigation 
and may shed light on the neurobiological factors of OBEs and NDEs (Luke, 2012, 2017).  
 
4.2. DMT and NDEs 
 
Following research investigating the phenomenological effects of administering intravenous 
injections of DMT, Strassman (2001) proposed DMT as an alternative endogenous NDE-ogen 
(causing an NDE) although one apparently independent of Jansen’s speculated NMDA-
antagonist neuroprotective mode of action. Given that the highly psychedelic molecule DMT 
is endogenous, Strassman proposed it as a ‘reality thermostat’ central to extraordinary events 
such as near-death and mystical experience, as well as birth and death. Speculating a pineal 
origin for DMT production, Strassman noted that the pineal gland is optimally situated to 
administer neurotransmitters to the brain via the cerebral spinal fluid following cardiac arrest, 
though one may ask what use this will be 10 seconds later once the brain’s electrical activity 
(and so presumably neurotransmission) has ceased. Nevertheless, DMT is virtually unique 
among endogenous neurotransmitters in that it is a molecule small enough to have blood-
brain barrier permeability (Jacob & Presti, 2005), and so can be easily absorbed into the brain 
via other routes. At this time, however, despite the discovery of DMT in the pineal glands of 
rats (Barker, Borjigin, Lomnicka & Strassman, 2013) and other indirect evidence (for a 
review see Luke, 2017), the speculation that DMT is made in the human pineal gland has yet 
to be demonstrated, though the evidence is mounting. More recently however a study 
exploring the post-cardiac arrest levels of brain chemicals in rats found a six-fold increase in  
occipital lobe DMT, comparable to concentrations of known canonical neurotransmitters 
(such as serotonin), independent of their having a pineal gland (Dean et al., 2019). These 
findings bolster the evidence for a possible role of DMT in NDEs but undermine the 
suggested necessity of the pineal gland as its site of origin.    
 
Nevertheless, despite the questionable role of the pineal gland Strassman (2001) also noted 
that the NDE has psychedelic and mystical qualities, and that the DMT experience often 
shares the same features as an NDE. Some of Strassman’s DMT study participants reported 
NDE-like experiences and death-rebirth experiences, with many others reporting a newfound 
fearlessness of death as occurs with an NDE. However, that the participants may have been 
inadvertently primed for these experiences cannot be ruled out because they were told in the 
briefing to expect feelings of death or impending death (Luke & Friedman, 2010). 
Nonetheless, at least one participant in the first ever study giving DMT to humans remarked, 
“This is death. How simple everything is” (Sai-Halász, Brunecker & Szára, 1958, p.4), and 
independent survey research indicates that DMT users sometimes do report death-like and 
near-death-type experiences, although such experiences were more typical with 5-MEO-DMT 
(Luke & Kittenis, 2005), a close chemical cousin.  
 
Not all researchers agree that DMT experiences mimic NDEs. Potts (2012) indicates that there 
are several typical features of the NDE that do not occur with DMT, and vice versa. However 
Potts’ comparison is not based on a systematic review or balanced sample of accounts and 
many of the features he lists as only occurring in NDEs (e.g., cosmic unity, peace, joy) are 
actually experienced in some DMT (e.g., Strassman, 2001) and ayahuasca experiences 
(Liester, 2013). Furthermore, a recent comparison of scores on items of Greyson’s NDE scale 
between 67 participants reporting NDEs and 13 participants injected with DMT found a 
significant overlap in almost all the psychometric features of the NDE, save for experience of 
reaching a border or point of no return (Timmermann, et al., 2018).   
 
Nevertheless, some of the weirder DMT features, such as encounters with clowns, elves and 
insectoid beings do tend to be absent from NDEs, as are the very common experience of 
colourful geometric patterns (form constants). However, in a systematic analysis of interviews 
with DMT experiencers one theme to emerge was the entities’ tendencies to impart insightful 
information about themselves and the universe in which they were inhabited, much like the 
positive performative role played by the apparently sentient beings encountered in near-death 
experiences, typically identified as deceased persons (Cott & Rock, 2008).  
 
Furthermore, countering Potts’ analysis, Liester (2013) conducted a more thorough qualitative 
comparison of experiences on ayahuasca with the nine classic features of the NDE as outlined 
by Moody (1989), the original cartographer of the NDE and the man who coined the term. 
Leister determined that eight of Moody’s nine key NDE elements could be found in 
ayahuasca experiences, although, as with DMT, some of the weirder entity encounters, such 
as elves and fairies were absent from the NDE cosmology. However, it should be noted that, 
historically, in folkloric accounts elves and fairies are commonly interpreted as spirits of the 
dead (Evans Wentz, 1911/2004; Lang, 1893; Luke, 2013b). Ideally, a systematic prospective 
phenomenological study, beyond the merely psychometric or functional and into the explicit 
content is required and myself and colleagues are currently conducting one. 
 
5. Entity encounters 
 
As discussed in the last section, encounters with seemingly sentient discarnate entities is a 
fairly common feature of the DMT experience, estimated by Strassman (2008) to occur in at 
least half of all high dose DMT participants, a figure supported by research with ayahuasca 
where 55% of participants reported entity encounters (Luke, 2009b). Entity encounter was 
also the second most common of 17 transpersonal experiences on DMT and ayahuasca (Luke 
& Kittens, 2005). Such an experience under the influence was also reported by 32% of 
psychoactive drug users generally and was reported to occur occasionally with a broad range 
of psychedelics, though not all (Luke & Kittenis, 2005). In a recent survey exploring the 
nature of experiences either with or without tryptamine psychedelics (LSD, psilocybin, 
ayahuasca or DMT) of encountering, “something that someone might call: God, Higher 
Power, Ultimate Reality, or an Aspect or Emissary of God (e.g., an angel)” (Griffiths, 
Hurwitz, Davis, Johnson & Jesse, 2019). Some two-thirds of those having such experience 
who reported being atheist before indicated that they no longer identified as being atheist after 
the experience. Overall there were few differences in the nature of these encounter 
experiences, but relative prevalence rates for the experience between different drugs is not 
currently available. Given that little research has been conducted on the encounter experience 
with substances other than DMT and ayahuasca (e.g., Luke, 2011; Shanon, 2002) so this brief 
review will focus on DMT.  
 
Having been first synthesised in 1931, isolated from a plant source in 1946, and discovered in 
human blood in 1965, it wasn’t until 1956 that the Hungarian chemist and psychiatrist 
Stephen Szára synthesised DMT in his lab and injected it into himself thereby discovering the 
its psychedelic effects (Gallimore & Luke, 2015). Szára went on to give DMT to his medical 
colleagues, one of whom reported that, “the whole room is filled with spirits” (Sai-Halász, 
Brunecker & Szára, 1958, p.4), while another noted that, “In front of me are two quiet, sunlit 
Gods” (p.7). Following Strassman’s (2001, p.185) later research injecting volunteers with 
DMT, experiencers frequently described the things they encountered as “entities, beings, 
aliens, guides or helpers,” which would appear as “clowns, reptiles, mantises, bees, spiders, 
cacti, and stick figures” as well as dwarves, elves, imps, angels, spirits, gods, or just as a 
presence, the latter four of which were commonly supremely powerful, wise, and loving. 
However, encounters with serpents and large felines, particularly black pumas are much more 
typical on ayahuasca (Shanon, 2002). Besides visionary encounters with people, animals and 
other ordinary things (which are not typical of DMT), the kinds of supernatural beings 
encountered on ayahusaca are classified by Shanon (2002) thus: 
 
1. Mythological beings: Such as gnomes, elves, fairies, and monsters of all kinds. 
2. Chimeras or hybrids: Typically half human half animal (e.g., mermaids), or transforming 
or shapeshifting beings, for example from human to puma, to tiger, to wolf. 
3. Extraterrestrials: These are particularly common for some experients and may be 
accompanied by spacecraft. 
4. Angels and celestial beings: Usually winged humanlike beings that may be transparent or 
composed of light 
5. Semi-divine beings: May appear like Jesus, Buddha, or typically Hindu, Egyptian or pre-
Columbian deities  
6. Demons, monsters and beings of death: Such as the angel of death 
 
A similar classification might also be applied to DMT entities. In addition another category, 
of plant teachers or plant spirits (explored further in a later section), should be added to 
Shanon's list, because these are regularly encountered on ayahuasca according to interviews 
with shamans and surveys of users (Luke, 2009b). In any case, encounters with elves, 
gnomes, pixies, dwarves, imps, goblins and other 'little people' (though clearly not human 
people), are extremely prevalent and have long been at the spearhead of the debate on the 
reality of DMT beings, and have been popularly dubbed the “self-transforming machine 
elves” (McKenna, 1991, p. 16). Leading the debate, Meyer (1996) indicates that, under the 
influence, the independent existence of these beings seems self-evident, but suggests that 
there are numerous interpretations of the entity experience. Meyer's and others' interpretations 
fall into three basic camps (Luke, 2011): 
 
I – Hallucination: The entities are subjective hallucinations. Such a position is favoured by 
those taking a purely (materialist reductionist) neuropsychological approach to the 
phenomena. One particularly vocal DMT explorer who adopted this neuro-reductionist 
approach, James Kent (Pickover, 2005, pp.104-105), appears to have taken a more ambiguous 
stance recently (Kent, 2010) by considering the entities simply as information generators. For 
Kent (2010), the question of the entities' reality is redundant given that they generate real 
information, and sometimes this seemingly goes beyond the experient's available sphere of 
knowledge (like psi). Nevertheless, according to Kent the entities cannot be trusted to always 
tell the truth and must be regarded as tricksters.   
 
II – Psychological/ Transpersonal: The entities communicated with appear alien but are 
unfamiliar aspects of ourselves (Turner, 1995), be that our reptilian brain or our cells, 
molecules or sub-atomic particles (Meyer, 1996). Alternatively, McKenna (1991, p. 43), 
suggests, “We are alienated, so alienated that the self must disguise itself as an extraterrestrial 
in order not to alarm us with the truly bizarre dimensions that it encompasses. When we can 
love the alien, then we will have begun to heal the psychic discontinuity that [plagues] us.”    
 
II – Other worlds: DMT provides access to a true alternate dimension inhabited by 
independently existing intelligent entities. The identity of the entities remains speculative, but 
they may be extraterrestrial or even extra-dimensional alien species, spirits of the dead or time 
travellers from the future (Meyer, 1996). A variation on this is that the alternate dimension, 
popularly termed hyperspace (e.g., Turner, 1995), is actually just a four-dimensional version 
of our physical reality (Meyer, 1996). The hyperspace explanation is one of the conclusions 
drawn by Evans-Wentz (1911/2004, p.482) following his massive folkloric study of 'the little 
people' (i.e., elves, pixies, etc.) and ties in somewhat with the extra-dimensional percepts 
discussed earlier:  
 
It is mathematically possible to conceive fourth-dimensional beings, and if they exist 
it would be impossible in a third-dimensional plane to see them as they really are. 
Hence the ordinary apparition is non-real as a form, whereas the beings, which wholly 
sane and reliable seers claim to see when exercising seership of the highest kind 
[perhaps under the influence of endogenous DMT], may be as real to themselves and 
to the seers as human beings are to us here in the third-dimensional world when we 
exercise normal vision.    
 
Clearly, no amount of speculation will reveal the true nature of such DMT 'visions' nor their 
entities and the ontological debate remains wide open without a scientific approach. At this 
juncture, parapsychology, and psychical research in particular, can lend over a century's worth 
of similar such enquiry to the issue. A case in point comes from a proposal by computer 
scientist Rodriguez (2007) to experimentally prove or disprove the entities’ existence. Grossly 
simplified, Rodriguez (2007) suggests obtaining from the entities solutions to complex 
mathematics puzzles that are unknown to the DMT participant communicating with them. 
Regrettably, this ingenious method for testing the reality of DMT entity encounters is subject 
to a number of flaws, aside from the huge assumptions involved in expecting our supposed 
hyper-intelligent beings having the desire to cooperate and make themselves 'proven'. The 
most crippling problem for Rodriguez’ test, however, is the super psi hypothesis, which has 
long proved difficult to surmount in parapsychological attempts to validate the existence of 
discarnate entities considered to be spirits of the dead, e.g. those apparently communicating 
via trance mediums. The problem is that, because psi has no theoretical or even apparent 
limits, it remains a possibility that any information provided by ostensibly discarnate entities 
may actually be due to the 'super' psi of the receiver (e.g., the medium or DMT explorer) 
receiving the information directly from an earthly incarnate source (e.g., see Braude, 2002, for 
a comprehensive discussion).  
 
A parallel debate aptly demonstrates how the super psi problem applies to Rodriguez' (2007) 
proposal. The living chess grandmaster Victor Korchnoi ostensibly played a high level game 
of chess with the deceased Hungarian grandmaster Géza Marcóczy via a non-chess playing 
automatic-writing medium (Eisenbeiss & Hassler, 2006), assuming no fraud was involved. 
Good evidence was presented that none other than a grandmaster of Marcóczy's standing, of 
which few if any are living, could have maintained that standard of playing over 47 moves, 
and so Neppe (2007) dismissed the super-psi hypothesis, but failed to consider the possibility 
that Korchnoi himself was the (living) source of such psi information (Breederveld, 2008). 
Such is the power of the super-psi hypothesis that it supersedes what would otherwise appear 
to be good evidence for post-mortem survival of the human personality: a similar curse awaits 
any such attempts to test the reality of DMT entities through ordinary informational means, be 
that maths puzzles, chess or otherwise.   
 
One alternative approach to investigating the ontology of shamanic entity encounters 
considers similarities in independent reports concerning the characteristics of particular 
entities, especially those encountered naïvely and without any cultural context from which the 
characteristics of the entity could be derived (Luke, 2008a). For instance, one such being that 
commonly appears to naïve DMT users is an entity consisting of multiple entwined serpents 
covered in multitudinous eyes, often forming a Fibonacci spiral-like geometrical shape. 
Obscure references to a similar mythological entity, sometimes identified as the angel of 
death, also exist in various cultural cosmologies, possibly indicating the transcultural nature 
of this entity (Luke, 2008a). Such data pose challenging questions as to whether the entity is 
culturally mediated – which seems unlikely given the obscurity of the cultural references – or 
a culture-free universal feature of DMT activation (naturally or artificially) in the brain, with 
possible incorporeal origins. A recent conversation with a 5-year old boy who described this 
exact entity and its activity in exquisite detail had me wondering whether the boy was a) 
generating an extremely elaborate spontaneous hoax, b) deeply psychic, or c) had genuinely 
encountered this entity on a regular basis during dreams and hypnogogia as he said he had 
(Luke, 2017). The evidence favoured one of the latter explanations.  
 
A similar phenomenological triangulation approach could fruitfully be made with other types 
of entities commonly encountered with DMT and ayahuasca, such as the bizarre 
preponderance of praying mantises (Luke, 2008b). It might be possible by such means to 
determine how statistically improbable is the occurrence of these shared visions. Such a 
methodology has its limitations, of course, nevertheless upon inspection of the literature it 
appears that such an approach has rarely been applied to the study of apparently collective 
visions and may point the baffled DMT ontologist in an enlightening direction, and this if the 
basis of an ongoing phenomenological analysis of discreet and complete experimental DMT 
datasets currently being undertaken by the author and colleagues. For further speculations and 
discussions among leading academics from different fields on the possible nature of DMT 
entities see Luke and Spowers (2018).  
 
6. Alien abduction 
 
The alien abduction experience is “a dynamic, elaborate and involved experience, rich in 
contextual detail” (Apelle, Lynn, Newman & Malaktaris, 2014, p.214), which usually 
involves the experiencer “waking up paralyzed with a sense of a strange figure or figures 
present, missing time,… balls of light” – features consistent with sleep paralysis –  along with 
memories of abduction, usually to somewhere interpreted as an alien spacecraft, and subjected 
to complex physical/psychological procedures. Typical features are capture, examination, 
communication with abductors (usually telepathically), an otherworldy journey, theophany, 
return and aftermath (Bullard, 1987). For an overview of theories explaining the experience 
see Apelle et al (2014). Prevalence figures are hard to ascertain, but certainly many thousands 
of Americans, in particular, believe they have been abducted by aliens (Apelle et al., 2014). 
There are no figures available for the prevalence of the experience with psychedelics and no 
known systematic research has been done.  
 
Psychedelic explorer McKenna (1991) posited that the visions of 4HO-DMT (psilocin) and of 
aliens and UFOs originated from the same source. Strassman (2001) developed this idea 
further and suggested that spontaneous endogenous DMT fluctuations could be at the root of 
alien abduction experiences as they share the same newly found fearlessness of death and 
visions of energy tunnels, or cylinders of light, in common with DMT experiences. Following 
the use of ayahuasca Severi (2003) also noted the similarity between NDEs, traditional 
psychedelic-induced shamanic initiations, alien abduction experiences, and heightened 
psychic sensitivity, as have previous researchers (e.g. Harvey-Wilson, 2001; Ring, 1989, 
1992). However, Barušs (2003) notes that, despite the similarities, DMT and alien abduction 
experiences lack specific commonalities, such as the absence with DMT of the classic grays 
(alleged small gray aliens). Nevertheless, Hancock (2005) argues that there are substantial 
similarities between aliens and 'elves', whether induced through DMT or else appearing in 
historic-folkloric legends and testimonies, speculating that the latter also have a DMT-
induced aetiology and, adopting the theory proposed by Vallee (1969), that these elves are the 
prototype encounter/abduction experiences. It should be noted that few experiencers ever 
doubt the reality of their encounters with either aliens (Mack, 1999) or DMT entities 
(Strassman, 2001).   
 
Furthermore, an insectoid alien, and especially praying mantis alien, sub-category might be 
added to Shanon’s (2002) bestiary of ayahuasca/DMT entities (Luke, 2008b, 2011). Ever 
since Leary’s (1966) account of his DMT encounter with metallic and bejewelled Venutian 
crickets, reports abound of mantid-like creatures performing exotic surgical operations and 
probe insertions on DMT experients, as well as those on psilocin (4HO-DMT), in a manner 
reminiscent of alien abduction cases (e.g., Kottmeyer, 1999; Mack, 1999). Concurrently, 
though probably starting somewhat later with Strieber (1987), mantises became a growing 
motif in the alien abduction literature, and one assumes that this was virtually independent 
from the DMT literature at this time – at least no one appears to have joined up the dots on 
insectoid encounters until Pickover (2005). For example, there was an article about the 
increasing presence of praying mantises in alien abduction cases in the 1990s, which were 
dubbed the ‘greying’ mantises as they appeared so often in people’s abduction experiences 
(Kottmeyer, 1999). However, this article was essentially entirely naïve to the DMT literature 
of this era, or at least it appears so, and yet we find a concordance between the alien abduction 
and DMT experiences, not least with this motif of the praying mantis, and with the elf-like 
characters too.  
 
7. Sleep paralysis 
 
The similarity between alien abduction experiences and sleep paralysis has been noted for 
some time (Hufford, 1982), and sleep paralysis has even been championed as an explanation 
for these bizarre experiences (Blackmore, 1998). Sleep paralysis is a relatively common 
parasomnic experience involving “a transient conscious state of involuntary immobility 
occurring immediately prior to falling asleep or upon wakening” and is accompanied by 
hypnogogic or hypnopompic perceptions such as an “evil presence,... auditory and visual 
hallucinations, pressure on the chest,… suffocating, chocking, floating, out-of-body, and 
flying sensations” (Cheyne, Rueffer & Newby-Clark, 1999, p.319-320).  
 
There are no published statistics and almost no direct commentaries on sleep paralysis and 
psychedelics, though it is worth noting that disrupted sleep patterns due to the stimulant 
effects of drugs can increase the incidence. It is apparent, however, that some of the DMT 
experiences reported in Strassman’s (2001) study, particularly the negative ones, share several 
features in common with sleep paralysis, particularly the sense of presence, reports of one’s 
chest being crushed, strange whistling, whining, and whirring sounds (as also occur in 
OBE/NDEs), and the terrifying paralysis of both body and vocal chords. Alien abduction 
experiences and NDEs are also associated with sleep paralysis (see Sherwood, 2002), and 
indeed Strassman (2008) later noted the apparent relationship between sleep paralysis and 
DMT experiences, although caution has been raised about claiming too many anomalous 
experiences can be explained by DMT, as this ultimately explains nothing (Luke, 2008b). 
Certainly further phenomenological analysis and a direct comparison of experiences is 
needed. Nevertheless, there certainly warrants something to research here regarding a DMT 
aetiology for sleep paralysis.  
 
Curiously, experiential reports from research programs in the 1950s and 1960s indicate that 
the endogenous 5-hydroxy-DMT (bufotenine), a very close relative to DMT with similar 
neurochemistry, might be considered as a chemical co-factor in such experiences, along with 
DMT. Much like DMT, bufotenine is reported on occasion to cause feelings of constriction in 
the throat and the crushing of one’s chest, as well as anxiety and fear reactions (Shulgin & 
Shulgin, 1997; Torres & Repke, 2006), much like sleep paralysis. Additionally, in South 
America and the Caribbean the entheogenic cohoba snuff is made from one of the few 
traditionally-used plants in which bufotenine is active, Piptadenia peregrina, and is used 
specifically to contact spirits (Cohen, 1970; Torres & Repke, 2006), perhaps somewhat like 
the sensed presences of sleep paralysis and numerous DMT experiences.  
 
However, Ott (2001) has pointed out that the circulatory crises in the earlier bufotenine 
research were most likely due to psychological factors caused by the enforced nature of the 
experiments – conducted as they were on psychiatric patients and prisoners with limited 
consent – because such experiences were absent during Ott’s own extensive self-
experimentation, and nor do indigenous users of plants containing bufotenine worry about or 
report respiratory arrest (Torres & Repke, 2006). In any case the breathing difficulties 
reported in sleep paralysis may be more to do with the paralysis of conscious bodily functions 
caused by being asleep, and the inability to inhale at will (which might in turn be partly 
responsible for causing the experience to be so terrifying). Furthermore, sensed presence, as 
opposed to direct perception of an entity, as often occurs with sleep paralysis, may be more 
common with other substances, such as Salvia divinorum (e.g., Addy, 2010; Arthur, 2010), or 
indeed in other non-drug induced altered states, such as that occurring within anechoic 
darkroom chambers, which induce sensed presences in about 10% of people spending 
approximately two-hours alone in the chamber (Luke, Timmermann, Kaelen & Bell-
Langford, 2019). As with many of these experience syndromes, however, further systematic 
phenomenological research is needed.  
 
8. Interspecies communication 
 
While alien entities and malevolent presences may occasionally be experienced on 
psychedelics, encounters with plant ‘spirits’ are much more commonly reported and are one 
of the core experiences among traditional practitioners of psychedelic shamanism (e.g., 
Beyer, 2009), which is always animistic (Narby, 2006). Survey results show that encountering 
the spirit or intelligence of the ingested plant or fungus was the most widely reported of a 
range of 17 transpersonal experiences occurring with those taking psilocybin-containing 
mushrooms, ayahuasca, Salvia divinorum and Amanita muscaria (Luke & Kittenis, 2005). On 
average, when people had such plant/substance encounter experiences they were reported to 
occur “often” with Psilocybe mushrooms, San Pedro and peyote cactus, and “occasionally” 
with the other plants mentioned, and were reported to occur under the influence by 42% of 
people using psychoactive substances generally (Luke & Kittenis, 2005), rising to up to 70% 
of people under the influence of ayahuasca (Luke, 2009).  
 
Interestingly, however, some people reported this experience with DMT and occasionally 
LSD too, the former of which is usually consumed as a plant extract and the latter of which is 
a semi-synthetic molecule. There were no reports in the survey of people encountering the 
spirit/intelligence of purely synthetic molecules like ketamine, dextromethorphan (DXM) or 
MDMA (Luke & Kittenis, 2005) revealing a graded relationship between the notion of 
sentience and the idea of life (Luke, 2006a). In interviews for his 100th birthday, LSD 
discoverer Albert Hofmann, having never revealed as much before, indicated that LSD had 
spoken to him and asked him to discover it (Luke, 2006b).  
 
When people do dialogue with Nature on psychedelics, there is often an ecological message, 
as might be expected, rebuking humanity for its widespread destruction of natural habitats 
(Krippner & Luke, 2009; Luke, 2013a). Such messages appear to be particularly vocal from 
psychedelic fungi, and interpreting humanity’s many dialogues on the mushroom experience 
mycophile Andy Letcher (2007) termed these mushroom-mediated encounters with discarnate 
spirit entities the animaphany. He warned, however, that these experiences largely go ignored 
because, in a Foucauldian sense, they offer a resistive discourse to that of the societally 
legitimated explanations of what occurs under the influence of such plants and fungi, in ‘the 
West’ at least (Foucault, 2006). Being based solely on the effects of mushrooms on others, the 
legitimated discourses typically take a pathological, psychological or prohibitory stance, and 
so the subjective animaphany appears to transgress a fundamental societal boundary, 
communicating with spirits, which subsequently becomes labelled as madness. But which is 
the more mad, communicating with the spirits of Nature or sitting back while Earth descends 
rapidly into the greatest wave of mass extinction in 65 million years, which at some estimated 
rates (Pimm, Russell, Gittleman, Brooks, 1995) would see all species on Earth extinct within 
the next 700 years?  
 
As much as the experience of animaphany is quite common with plant psychedelics, there 
were until recently no published statistics available on how many people having had that 
experience are re-orientated to be more ecologically minded than before. In a survey I 
conducted (Luke & Yanakieva, 2016) on the contribution of psychedelic experiences to eco-
consciousness. Nearly 80% of the 150 psychedelic using respondents reported that their use of 
psychedelics had increased their subsequent degree of interaction with nature, with almost 
none saying it had reduced their interaction. Indeed, all of the respondents reported that their 
connection with nature had increased following their use of psychedelics, and more than 60% 
said that their concern had also increased. These figures compare quite well with respondents 
in a different survey (Ring, 1992), that found that 70-80% of those having near-death 
experiences (NDEs), and 80-86% of those having UFO encounter and/or alien abduction 
experiences had increased ecological concerns following their experience, giving some 
support to notion that there is an overlap between NDEs, traditional psychedelic-induced 
shamanic initiations, alien abduction experiences, and heightened psychic sensitivity (Harvey-
Wilson, 2001; Ring, 1989, 1992; Severi, 2003).  
 
Interestingly, in our survey, the substance most commonly reported to increase connection 
was psilocybin-containing mushrooms, which resulted in increased eco-connectedness in 
almost half of all mushroom users. Furthermore, approximately one third of magic mushroom 
users reported encounter experiences with the spirit or intelligence of the ingested mushroom, 
while some 16% reported encounters with animal spirits or communicating with animals 
whilst high, and 10% reported the experience of being transformed into another species – an 
experience reported by a full quarter of all ayahuasca users (Luke & Yanakieva, 2016).  
 
One thing that seems apparent now since conducting the first survey exploring psychedelic-
induced changes in eco-consciousness (Luke & Yanakieva, 2016) – now that there is some 
data on the subject rather than just anecdote – is that, according to self-report, psychedelics do 
indeed tend to increase user’s interaction with, connection to, and concern for Nature. Indeed, 
a recent open-label psilocybin treatment study for depression found that ‘nature relatedness’ 
significantly increased relative to baseline following the ingestion of psilocybin, with changes 
remaining significant when measured again up to 12 months later (Lyons & Harris, 2018). A 
survey by Forstmann and Sagioglou (2017) similarly found that lifetime use of psychedelics 
was significantly associated with nature relatedness in terms of self-identification with nature 
and the desire to be in natural environments, and that the influence of nature relatedness on 
pro-environmental behaviour was mediated by the lifetime use of psychedelics. 
 
Further to that, those taking psychedelics (especially organic ones) say that their experiences 
not only changed their attitudes but also directly changed their eco-orientated behaviour. In 
our survey (Luke & Yanakieva, 2016), the majority of psychedelic users reported adjusting 
their diet (presumably towards organic, raw, vegetarian or vegan) and increasing gardening as 
a result of their psychedelic experiences. Some 16% reported changing their entire careers to 
more eco-oriented ones, such as switching to studying PhDs in botany (reported by two 
people in the sample), and 19% also reported becoming more actively engaged in ecological 
activism.  
 
In a recent article written by a doctor of molecular biophysics turned eco-activist and founder 
of one of the UK’s fastest growing social movements, Extinction Rebellion, Gail Bradbrook 
(2019) indicates how her experiences with iboga and ayahuasca gave her the template for 
forming the radical environmental action group fighting against anthropogenic species 
extinction, ecocide and climate change. During her psychedelic experiences she had prayed 
for ‘the codes for social change’ and upon returning from her psychedelic quest quickly met 
the climate activist and doctoral researcher of effective radical campaign design Roger 
Hallam who offered her what he specifically also called the “codes for social change”, and 
together they formed Extinction Rebellion. In a time of such global ecological crisis 
psychedelics might just have an essential role in literally ‘saving the planet’, and the 
importance of interspecies relationships in this endeavour should not be overlooked but, 




Possession can be defined as “…the hold over a human being by external forces or entities 
more powerful than she. These forces may be ancestors or divinities, ghosts of foreign origin, 
or entities both ontologically and ethnically alien...Possession, then, is a broad term referring 
to an integration of spirit and matter, force or power and corporeal reality, in a cosmos where 
the boundaries between an individual and her environment are acknowledged to be 
permeable, flexibly drawn, or at least negotiable..." (Boddy, 1994, p. 407). 
 
Given the relative propensity with which a large proportion of those taking psychedelic 
substances have entity encounters it may be somewhat surprising then that the report of 
involuntary possession and the practice of voluntary possession (usually termed 
incorporation) are quite rare (Luke, 2014). Survey research indicates that 19% of people using 
psychoactive drugs have had mediumistic experiences under the influence, however this was 
also the most typical transpersonal experience with alcohol, of all drugs, although occurred 
only with 1-2% of drinkers (Luke & Kittenis, 2005). Reports of mediumstic experience on 
ayahasuca was reported by 40% of users (Luke, 2009b). However communication with the 
dead does not imply possession, and reports of spontaneous states of apparently 
psychedelically-induced possession have not been surveyed, but a few cases are evident, if 
quite rare (Luke, 2014). Alternatively the practice of incorporation (sometimes called trance 
possession) under the influence of psychedelics is somewhat more widespread within 
shamanic cultures but is also quite an exception.  
 
In a survey of 42 different shamanic-like groups from across the globe (Peters & Price-
Williams, 1980) some 69% practiced some form of spirit possession, but of these only two 
groups (7%) are particularly renowned for their use of psychoactive plants: the tobacco-using 
Akawaio and the Amanita muscaria mushroom-using Chukchi (Luke, 2014). An educated 
estimate would put the proportion of shamanic cultures utilising psychedelic possession at 
5%, a figure which can be halved if indigenous tobacco use is discounted as psychedelic 
(Luke, 2014). Furthermore, among shamanic groups there is a tendency for incorporation to 
be practised more in sub-Saharan Africa and psychedelic plant shamanism to be practiced 
more in the Americas (Bourguignon, 1976; Schultes & Hofmann, 1992). Taxonomical 
analysis of phenomenological variables among culturally disparate groups practicing 
traditional magico-religious healing also identifies somewhat distinct categories (Winkelman, 
1990). Those termed shamans or shaman-healers made use of psychedelic plants and magical 
flight, whereas those termed mediums did not make use of psychedelics and (all but one 
group) engaged in ‘possession trance’ (incorporation). 
 
Of course, there are some other examples of indigenous groups who utilise psychedelic plant 
shamanism in conjunction with incorporation, but these seem to be the exception rather than 
the rule. Besides the two already mentioned, a preliminary search of the relevant literature 
only reveals three more (Luke, 2014). The Yanomami of Venezuela (e.g., Jokic, 2008) who 
utilise ‘epena’ or ‘yopo’ snuff (usually derived from Anadenanthera peregrina seeds), and 
incorporate various hekura spirits. The second is the Mitsogho people of Gabon who utilise 
both iboga (Tabernanthe iboga) and incorporation in their rituals (Maas & Strubelt, 2003), 
although this is apparently reserved for female Ombwiri (or Ombudi) trance possession 
initiates only, who may use the iboga to assist in their vision of the healing genies (Goutarel, 
Gollnhofer, & Sillans, 1993). The final group is not a traditional indigenous shamanic group 
but a modern religious movement that fuses the Brazilian syncretic Christian ayahuasca 
church, Santo Daime, with the Afro-Brazilian trance possession cult Umbanda, giving rise to 
a super-syncretic eclectic new religious practice called Umbandaime (Dawson, 2012), which 
utilises incorporation within ayahuasca use.  
 
One theory put forward for the apparent preference for ‘magical flight’ over incorporation 
among shamans (Eliade, 1972) is that shamanism is not about relinquishing control to the 
spirits but about controlling them so they can do one’s bidding (McKenna, 1992). Indeed, in 
the case of the Akawaio and Yanomami, their incorporation often involves the control of 
multiple spirits simultaneously rather than the simple ‘one host one spirit’ typical of ritual 
incorporation practices, and the concept of controlling spirits rather than communicating with 
them is key (Luke, 2014). So apparent psychedelic incorporation is not your typical 
mediumstic trance possession among traditional shamanic groups, and conversely the modern 
urban practice of Umbandaime, although having shamanic origins, is more a religious than a 
shamanic practice. Ultimately, this religionising of the shamanic practice of ayahuasca use 
along the dimension, delineated by Winkelman, arising as shamanism moves from nomadic 
and hunter-gatherer groups towards sedentary politically integrated ‘mega-citizens’ may be 
indicative of a prototypical supersyncretic suburban shamanism of the future (Luke, 2014).  
 
10. Psi: Telepathy, precognition, and clairvoyance and psychokinesis 
 
So far, the experiences discussed in this paper, with the exception of synaesthesia, have all 
offered anomalies not just of the rare kind, but also of the kind that might “contravene 
assumptions about reality” (Holt et al., 2012, p.2), especially if they are taken at face value. 
Nevertheless, all of these anomalous experiences have numerous problems associated with 
determining their fundamental reality, and debates abound, but no theories are conclusively 
supported. How, then, is it possible to discern the true ontological nature of these 
extraordinary experiences? Psi experiences (telepathy, precognition, and clairvoyance and 
psychokinesis) are no less controversial, perhaps more so, however, they are much more 
amenable to controlled scientific testing, and, even if disputed, clear interpretable scientific 
data can support hypotheses or not. Of course, most of those conducting psi research would 
say that there is good evidence for psi overall when the meta-analyses of various research 
strands are considered (e.g., Radin, 2006), whereas critics, who typically do not conduct such 
experimental work, would say that the evidence is not sufficient (e.g., French, 2010). See 
Krippner and Friedman (2010) for a balanced debate. In any case, the veridicality or not of 
psychedelic psi experiences may shed some light on the veracity of other anomalous 
psychedelic experiences, for if people are having genuine psi experiences on psychedelics, as 
shamans would claim, then some of these other anomalous experiences may also be genuine, 
i.e., as they appear at face value (Luke, 2011).  
 
The following paragraphs explore the evidence for psychedelic psi, although it must be 
pointed out there are very few reports of psychokinesis (PK) – the direct control of matter 
with the mind – and virtually no experimental research, so the term psi here refers only to the 
receptive and informational forms – telepathy, clairvoyance and precognition – once known 
collectively as extrasensory perception (ESP). Unlike PK, which is reported to occur under 
the influence by only 22% of psychoactive drug users (Luke & Kittenis, 2005) there is ample 
data available to indicate that such psychedelic ESP experiences are quite prevalent. For 
example, the traditional divinatory and shamanic use of psychedelic plants is widely reported 
in the historical, anthropological, and ethnobotanical record (for a review see Luke, 2012). 
Later, as these substances became discovered, invented and researched by ‘Western’ 
explorers and scientists many of them also reported psychedelic ESP experiences (e.g., 
Osmond, 1961; Wasson & Wasson, 1957) and prospective psychedelic users were warned 
they might expect such an experience (Leary, Metzner, & Alpert, 1964).  
 
Outside of laboratory research the initial context in the developed world for using 
psychedelics was within psychotherapy and practically every psychedelic psychotherapist 
who has written about their work has reported the occurrence of ESP, and indeed other 
anomalous experiences, within therapy (for a review see Luke, 2012). At one time it was 
estimated that ESP occurs with good supporting evidence in about 2% of such therapy 
sessions, which is a considerably higher incidence than that reported to have occurred in non-
psychedelic psychotherapy (Luke & Friedman, 2010). Among the general public, surveys 
consistently indicate those reporting anomalous experiences are significantly more likely to 
have used psychedelic substances, with more frequent use associated with a greater likelihood 
of an experience (Luke, 2012). Of those reporting the use of psychedelics, percentages for 
reported psi experiences actually occurring under the influence ranged from 18% (psi 
experiences on mind-expanding drugs in India; Usha & Pasricha, 1989a, 1989b) up to 83% 
(telepathy experiences on cannabis in 1970s California; Tart, 1993). The most common 
experiences were telepathy.  
 
A consistent trend in the literature indicates that anomalous experiences tend to occur far 
more with psychedelics than with other psychoactive substances. In surveys the consistent 
correlation of psychedelic use with paranormal experiences, belief, and fearlessness tended to 
be either greatly reduced or reversed with respect to the non-psychedelic substances of 
cocaine, heroin, and alcohol, supporting the same trend in individual reports and folklore 
(Luke, 2012). Experiences of telepathy were most commonly associated with cannabis, and, 
to a lesser extent, with LSD, and particularly with MDMA, a drug which is characterized by 
its capacity to induce empathic experiences. Group telepathy experiences, specifically, were 
also consistently reported with DXM, an NMDA-antagonist like ketamine. Precognition 
experiences were less common and occurred with most classic psychedelics but were not 
particularly typical to any one substance, whereas clairvoyance, although only somewhat 
more common than precognition, was most likely to occur with cannabis, LSD and psilocybin 
(Luke & Kittenis, 2005).  
 
Although it is recognized that subjective reports are not scientifically rigorous in establishing 
the veridical nature of these experiences, they enhance our understanding and offer a rich 
phenomenological spectrum of evidence around which to orient further research. 
Furthermore, the similarity in reports between those occurring spontaneously in exploratory, 
therapeutic, and accidental contexts and those induced intentionally in the traditional ritual 
context gives further credence to the shamanic use of these substances for paranormal 
purposes. 
 
With regard to controlled research on the efficacy of psychedelics to induce ESP, there have 
been only 17 separately published experimental projects that have been conducted – primarily 
with LSD or psilocybin, but also with mescaline, marijuana, Amanita muscaria, and, recently, 
ayahuasca. The results of these experiments, which began in the 1950s, varied in their degree 
of success, most likely in relation to the methodology involved (for a review see Luke, 2012). 
The most successful experiments tended to utilize participants experienced with the use of 
psychedelics and also incorporated free-response testing procedures with open-ended 
mentation regarding their internal state, rather than forced-choice guessing scenarios that 
tended to be repetitive and thus rather boring under the influence. In retrospect, it is easy to 
see how the more naïvely designed projects lost any hope of sensibly testing for anything, let 
alone psi, once their inexperienced participants began succumbing to the mystical rapture of 
their first trip. 
 
Overall, few firm conclusions can be drawn concerning the induction of genuine psi with 
psychedelics because of the lack of systematically controlled experiments, although, at best, 
the results suggest a promising line of enquiry, which after a long hiatus is now resuming with 
better methodology (Luke, 2009b, 2017). Furthermore, this approach is useful for 
understanding the neurobiological processes that may be at work during anomalous 
experiences, whether they are genuinely paranormal or not.  
 
Summary & Conclusions  
 
While there is a basic overview available here of the induction of anomalous experiences with 
psychedelic substances it is clear that systematic study in this area is at a nascent stage or, as 
with extra-dimensional percepts, barely even started. This is somewhat unfortunate because 
by exploring psychedelics there may be a lot to be learned about the neurobiology involved in 
these various anomalous experiences, as is proposed by the DMT and ketamine models of 
NDE. However, one important thing seems apparent from the data, and that is that altered 
states of consciousness, as opposed to psychedelic chemicals per se, seem to be key in the 
induction of such experiences, at least where they are not congenital: for every experience 
presented here, and more, can also occur in non-psychedelic states. As such, it may well be 
the states produced by psychedelics and other means of inducing ASCs that are primary, not 
the neurochemical action. Of course all states of consciousness probably involve changes in 
brain chemistry, such as occurs with the simple change of CO2 in blood induced by breathing 
techniques or carbogen (Meduna, 1950), but there are many states and many neurochemical 
pathways and yet so many of these can give rise to the same experience syndromes as 
described in this essay. Indeed, it should be remembered that the experiential outcome of an 
ASC is determined not just by substance (which could be any ASC technique) but by set and 
setting too (Leary, Litwin & Metzner, 1963).  
 
Curiously, recent brain imaging research with psilocybin has demonstrated that, counter to 
received neuroscientific wisdom, no region of the brain was more active under the influence 
of this substance but several key hub regions of the cortex – the thalamus, anterior and 
posterior cingulate cortex (ACC & PCC), and medial prefrontal cortex (mPFC) – 
demonstrated reduced cerebral blood flow (Carhart-Harris et al., 2012). Similar findings have 
been demonstrated with other ASCs, such as with experienced automatic writing trance 
mediums (Peres et al., 2012). These findings seem to support Dietrich’s (2003) proposal that 
all ASCs are mediated by a transient decrease in prefrontal cortex activity, and that the 
different induction methods – be it drugs, drumming, dreaming, dancing or diet – affect how 
the various prefontal neural pathways steer the experience. In this sense then, there are many 
mechanisms for a general altered state, in which many anomalous experiences are possible, 
but which ultimately have their own flavour in line with the method of induction.  
 
These brain imaging studies and other evidence (e.g., see Kastrup, 2012; Luke, 2012), also 
tentatively support Aldous Huxley’s (1954) extension of Henri Bergson’s idea that the brain 
is a filter of consciousness and, according to Huxley, that psychedelics inhibit the brain’s 
default filtering process thereby giving access to mystical and psychical states. In any case, 
even if specific neurobiological processes can be identified in the induction of specific 
anomalous experiences, or even states, does not mean to say that a reductionist argument has 
prevailed, because as Huxley also stated, psychedelics are the occasion not the cause – the 
ontology of the ensuing experience still needs fathoming whether the neurobiological 
mediating factors are determined or not. Ultimately, the importance of these anomalous 
experiences may be determined by what we can learn about ontology, consciousness and our 
identity as living organisms, and by what use they may be in psychotherapy, one’s own 
spiritual quest, and as catalysts for personal transformation and healing (Roberts & 
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